News Conference News ACC 2019 Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks Todd Neale March 07, 2019
News Conference News ISC 2019 Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes? Todd Neale February 14, 2019
News Conference News ISC 2019 Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke Todd Neale February 12, 2019
News Conference News ISC 2019 Getting Women More Involved at the International Stroke Conference: Theories, Data, and Solutions Todd Neale February 12, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News WCC 2018 E-Cigarettes: Plausible Heart Risks Flagged in New Review Todd Neale December 10, 2018
News Conference News WCC 2018 Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab Todd Neale December 07, 2018
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Conference News AHA 2018 Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis Todd Neale November 19, 2018
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018